Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease

Journal of the American Society of Nephrology

Volumn 16, Issue 6, 2005, Pages 1803-1810

  Weiner, Daniel E ^a   Tighiouart, Hocine ^a   Vlagopoulos, Panagiotis T ^a   Griffith, John L ^a   Salem, Deeb N ^a   Levey, Andrew S ^a   Sarnak, Mark J ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; ANAMNESIS; ANEMIA; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; CREATININE BLOOD LEVEL; DEATH; DEMOGRAPHY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; ETHNOLOGY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEMATOCRIT; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK FACTOR; STROKE; SURVIVAL; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; KIDNEY DISEASE; LONGITUDINAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT;

AGED; ANEMIA; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 26944442801     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004070597     Document Type: Article

References (29)

1. Muntner P, He J, Hamm L, Loria C, Whelton PK: Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13: 745-753, 2002
2. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 15: 1307-1315, 2004
3. Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD: Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney M 62: 1402-1407, 2002
4. Wheeler DC, Townend JN, Landray MJ: Cardiovascular risk factors in predialysis patients: Baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study. Kidney Int 63[Suppl 84]: S201-S203, 2003
5. London GM: Left ventricular hypertrophy: Why does it happen? Nephrol Dial Transplant 18[Suppl 8]: viii, 2-6, 2003
6. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27: 347-354, 1996
7. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O: Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 34: 125-134, 1999
8. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J: Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 162: 1401-1408, 2002
9. Jurkovitz CT, Abramson JL, Vaccarino LV, Weintraub WS, McClellan WM: Association of high serum creatinine and anemia increases the risk of coronary events: Results from the prospective community-based Atherosclerosis Risk in Communities (ARIC) study. J Am Soc Nephrol 14: 2919-2925, 2003
10. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W: Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: The ARIC study. Kidney Int 64: 610-615, 2003
11. The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. The ARIC investigators. Am J Epidemiol 129: 687-702,1989
12. Dawber TR, Kannel WB: An epidemiologic study of heart disease: The Framingham study. Nutr Rev 16: 1-4, 1958
13. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary DH, Psaty B, Rautaharju P, Tracy RP, Weiler PG: The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1: 263-276, 1991
14. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP: An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 110: 281-290, 1979
15. Levey AS, Greene T, Kusek JW, Beck GJ: A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 11: 155A, 2000
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
17. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS: Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39: 920-929, 2002
18. Culleton BF, Larson MG, Evans JC, Wilson PW, Barrett BJ, Parfrey PS, Levy D: Prevalence and correlates of elevated serum creatinine levels: The Framingham Heart Study. Arch Intern Med 159: 1785-1790, 1999
19. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation: National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139: 137-147, 2003
20. World Health Organization: Nutritional Anaemias: Report of a WHO Scientific Group, Geneva, World Health Organization, 1968
21. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P: Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 286: 180-187, 2001
22. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ: Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38: 955-962,2001
23. Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P: Electrocardiographic left ventricular hypertrophy in renal transplant recipients: Prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 14: 462-468, 2003
24. Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM: Pathophysiology of anaemia: Focus on the heart and blood vessels. Nephrol Dial Transplant 15[Suppl 3]: 14-18, 2000
25. Middleton RJ, Parfrey PS, Foley RN: Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12: 1079-1084, 2001
26. Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J: Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 65: 1031-1040, 2004
27. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003
28. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659-663, 2004
29. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13[5 Suppl]: 180-193, 1989